Conference Proceedings and videos for the 2020 Global Conference on Regulatory Science are now up!
READ THE REPORT NOW
Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
Featured Publications
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
RegSci Forum: Benefit-Risk Analysis of Regulatory Decision-Making
GK Raju | May 11, 2021 12-1pm ET
Virtual Webconference
Twitter @Harvardmit_CRS
Happening TODAY from 12-1pm ET! Join us!
Benefit-Risk Analysis to Capture Regulatory Decision-Making
GK Raju, Chairman and CEO, @LightPharma
RSVP here: https://doodle.com/poll/u36pxg7kicacv575
Congratulations to @ArfeAndrea, research fellow with the @LorenzoTrippa lab & the @DanaFarber Program in Regulatory Science, on joining the @sloan_kettering @MSKBiostats faculty! 🎉 https://twitter.com/HarvardMIT_CRS/status/1389946727684263944
Our first speaker for #RegSci2021 Lab Meeting is @ArfeAndrea, current @HarvardMIT_CRS @Bos_CHIP @DFCIDataScience fellow and soon-to-be @Sloan_Kettering @MSKBiostats faculty, who is discussing "Timing of pediatric and adult clinical trials in oncology"
Our second speaker for #RegSci2021 Lab Meeting is @AleAviP @HarvardMIT_CRS @DFCIDataScience, who is discussing "Subgroup information borrowing in basket trials via informative priors for clustering"
Our first speaker for #RegSci2021 Lab Meeting is @ArfeAndrea, current @HarvardMIT_CRS @Bos_CHIP @DFCIDataScience fellow and soon-to-be @Sloan_Kettering @MSKBiostats faculty, who is discussing "Timing of pediatric and adult clinical trials in oncology"
I had a terrific time discussing my work and experiences as an @ORISEaspire Fellow at @US_FDA. Thanks for having me, @HarvardMIT_CRS and TGP! https://twitter.com/HarvardMIT_CRS/status/1382460362444914689
Our next #RegSci2021 Early Career Seminar on April 29th features recent @Harvard @HMSHCP health economics PhD graduate and current Public Health and Regulatory Research Fellow at @US_FDA, Dr. @AbelleFowler!
RSVP here: https://www.eventbrite.com/e/regsci-early-career-seminar-tickets-149735716559